Value Investing Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: MCsweet who wrote (54255)	8/14/2014 3:47:05 PM
From: Jurgis Bekepuris	Read Replies (1) of 78673

ASDS - I took another look. I am still concerned about the $5M investment on the books. The divvie paid by it is really low ($10K per quarter?). It's tough to say if carrying it at cost hides an issue (it's not worth the cost and company is hiding the roaches) or an opportunity (it's worth more than the cost and company is hiding a gem). On the positive side, Q1 FCF was 200K vs. 65K in earnings. Assuming we can trust CF more, this is good. I don't understand this: Payments on notes payable (3,684) (3,936) Proceeds from notes payable 3,621 3,617 Are they turning around their notes every quarter? WTH is this? It seems to me that independent drugstore business should suck in this age of chains that have agreements with insurers + internet. I am not sure I would trust them not to overpay. So I think I am still not buying. Any comments?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next